SUSAN BLANEY to Myelodysplastic Syndromes
This is a "connection" page, showing publications SUSAN BLANEY has written about Myelodysplastic Syndromes.
Connection Strength
0.319
-
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. J Clin Oncol. 2011 Jan 20; 29(3):316-23.
Score: 0.319